Cargando…

Talampanel reduces the level of motoneuronal calcium in transgenic mutant SOD1 mice only if applied presymptomatically

We tested the efficacy of treatment with talampanel in a mutant SOD1 mouse model of ALS by measuring intracellular calcium levels and loss of spinal motor neurons. We intended to mimic the clinical study; hence, treatment was started when the clinical symptoms were already present. The data were com...

Descripción completa

Detalles Bibliográficos
Autores principales:	Paizs, Melinda, Tortarolo, Massimo, Bendotti, Caterina, Engelhardt, Jozsef I, Siklós, László
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Informa Healthcare 2011
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3231880/ https://www.ncbi.nlm.nih.gov/pubmed/21623665 http://dx.doi.org/10.3109/17482968.2011.584627

Ejemplares similares

Altered Metabolic Profiles Associate with Toxicity in SOD1(G93A) Astrocyte-Neuron Co-Cultures
por: Valbuena, Gabriel N., et al.
Publicado: (2017)

Spinal Cord Metabolic Signatures in Models of Fast- and Slow-Progressing SOD1(G93A) Amyotrophic Lateral Sclerosis
por: Valbuena, Gabriel N., et al.
Publicado: (2019)

Mutant Copper-Zinc Superoxide Dismutase (SOD1) Induces Protein Secretion Pathway Alterations and Exosome Release in Astrocytes: IMPLICATIONS FOR DISEASE SPREADING AND MOTOR NEURON PATHOLOGY IN AMYOTROPHIC LATERAL SCLEROSIS
por: Basso, Manuela, et al.
Publicado: (2013)

Passive Transfer of Blood Sera from ALS Patients with Identified Mutations Results in Elevated Motoneuronal Calcium Level and Loss of Motor Neurons in the Spinal Cord of Mice
por: Polgár, Tamás F., et al.
Publicado: (2021)

Muscle cells and motoneurons differentially remove mutant SOD1 causing familial amyotrophic lateral sclerosis
por: Onesto, Elisa, et al.
Publicado: (2011)

Comparative Magnetic Resonance Imaging and Histopathological Correlates in Two SOD1 Transgenic Mouse Models of Amyotrophic Lateral Sclerosis
por: Caron, Ilaria, et al.
Publicado: (2015)

Cytotoxic CD8(+) T lymphocytes expressing ALS-causing SOD1 mutant selectively trigger death of spinal motoneurons
por: Coque, Emmanuelle, et al.
Publicado: (2019)

T(2)-weighted MRI detects presymptomatic pathology in the SOD1 mouse model of ALS
por: Evans, Matthew C, et al.
Publicado: (2014)

Astrocytes expressing mutant SOD1 and TDP43 trigger motoneuron death that is mediated via sodium channels and nitroxidative stress
por: Rojas, Fabiola, et al.
Publicado: (2014)

Gene expression changes in spinal motoneurons of the SOD1(G93A) transgenic model for ALS after treatment with G-CSF
por: Henriques, Alexandre, et al.
Publicado: (2015)

Motoneuronal inflammasome activation triggers excessive neuroinflammation and impedes regeneration after sciatic nerve injury
por: Molnár, Kinga, et al.
Publicado: (2022)

SOD1 silencing in motoneurons or glia rescues neuromuscular function in ALS mice
por: Dirren, Elisabeth, et al.
Publicado: (2015)

RNS60 exerts therapeutic effects in the SOD1 ALS mouse model through protective glia and peripheral nerve rescue
por: Vallarola, Antonio, et al.
Publicado: (2018)

The anabolic/androgenic steroid nandrolone exacerbates gene expression modifications induced by mutant SOD1 in muscles of mice models of amyotrophic lateral sclerosis
por: Galbiati, Mariarita, et al.
Publicado: (2012)

Hippocampal CA1 Pyramidal Neurons of Mecp2 Mutant Mice Show a Dendritic Spine Phenotype Only in the Presymptomatic Stage
por: Chapleau, Christopher A., et al.
Publicado: (2012)

Motoneuron double discharges: only one or two different entities?
por: Kudina, Lydia P., et al.
Publicado: (2013)

Upregulation of Nucleotide-Binding Oligomerization Domain-, LRR- and Pyrin Domain-Containing Protein 3 in Motoneurons Following Peripheral Nerve Injury in Mice
por: Nógrádi, Bernát, et al.
Publicado: (2020)

Intraperitoneally administered IgG from patients with amyotrophic lateral sclerosis or from an immune-mediated goat model increase the levels of TNF-α, IL-6, and IL-10 in the spinal cord and serum of mice
por: Obál, Izabella, et al.
Publicado: (2016)

Presymptomatic Treatment with Acetylcholinesterase Antisense Oligonucleotides Prolongs Survival in ALS (G93A-SOD1) Mice
por: Marc, Gotkine, et al.
Publicado: (2013)

RNA-Seq Profiling of Spinal Cord Motor Neurons from a Presymptomatic SOD1 ALS Mouse
por: Bandyopadhyay, Urmi, et al.
Publicado: (2013)

Actions of the antihistaminergic clemastine on presymptomatic SOD1-G93A mice ameliorate ALS disease progression
por: Apolloni, Savina, et al.
Publicado: (2016)

Corrigendum to “Presymptomatic Treatment with Acetylcholinesterase Antisense Oligonucleotides Prolongs Survival in ALS (G93A-SOD1) Mice”
por: Gotkine, Marc, et al.
Publicado: (2015)

Impairment of mitochondrial calcium handling in a mtSOD1 cell culture model of motoneuron disease
por: Jaiswal, Manoj Kumar, et al.
Publicado: (2009)

Motoneuron Differentiation of Induced Pluripotent Stem Cells from SOD1G93A Mice
por: Yao, Xiao-Li, et al.
Publicado: (2013)

Correction: Motoneuron Differentiation of Induced Pluripotent Stem Cells from SOD1G93A Mice
por: Yao, Xiao-Li, et al.
Publicado: (2013)

Motoneuronal Spinal Circuits in Degenerative Motoneuron Disease
por: Falgairolle, Mélanie, et al.
Publicado: (2020)

Comparison of dendritic calcium transients in juvenile wild type and SOD1(G93A) mouse lumbar motoneurons
por: Quinlan, Katharina A., et al.
Publicado: (2015)

Time Course of Alterations in Adult Spinal Motoneuron Properties in the SOD1(G93A) Mouse Model of ALS
por: Huh, Seoan, et al.
Publicado: (2021)

Design of a Randomized, Placebo-Controlled, Phase 3 Trial of Tofersen Initiated in Clinically Presymptomatic SOD1 Variant Carriers: the ATLAS Study
por: Benatar, Michael, et al.
Publicado: (2022)

Clearance of the mutant androgen receptor in motoneuronal models of spinal and bulbar muscular atrophy()
por: Rusmini, Paola, et al.
Publicado: (2013)

Caudal–Rostral Progression of Alpha Motoneuron Degeneration in the SOD1(G93A) Mouse Model of Amyotrophic Lateral Sclerosis
por: Kirby, Alastair J., et al.
Publicado: (2022)

Phenotypic Alterations in Hippocampal NPY- and PV-Expressing Interneurons in a Presymptomatic Transgenic Mouse Model of Alzheimer’s Disease
por: Mahar, Ian, et al.
Publicado: (2017)

Correction to: Design of a Randomized, Placebo-Controlled, Phase 3 Trial of Tofersen Initiated in Clinically Presymptomatic SOD1 Variant Carriers: the ATLAS Study
por: Benatar, Michael, et al.
Publicado: (2022)

Presymptomatic grey matter alterations in ALS kindreds: a computational neuroimaging study of asymptomatic C9orf72 and SOD1 mutation carriers
por: Bede, Peter, et al.
Publicado: (2023)

Peripheral administration of SOD1 aggregates does not transmit pathogenic aggregation to the CNS of SOD1 transgenic mice
por: Keskin, Isil, et al.
Publicado: (2021)

Correlative light and electron microscopy suggests that mutant huntingtin dysregulates the endolysosomal pathway in presymptomatic Huntington’s disease
por: Zhou, Ya, et al.
Publicado: (2021)

Rhes depletion promotes striatal accumulation and aggregation of mutant huntingtin in a presymptomatic HD mouse model
por: Pan, Yongcheng, et al.
Publicado: (2023)

An examination of wild-type SOD1 in modulating the toxicity and aggregation of ALS-associated mutant SOD1
por: Prudencio, Mercedes, et al.
Publicado: (2010)

Anti-SOD1 Nanobodies That Stabilize Misfolded SOD1 Proteins Also Promote Neurite Outgrowth in Mutant SOD1 Human Neurons
por: Kumar, Meenakshi Sundaram, et al.
Publicado: (2022)

The p97‐Nploc4 ATPase complex plays a role in muscle atrophy during cancer and amyotrophic lateral sclerosis
por: Re Cecconi, Andrea David, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2r3lmmah3eo9u1kmbhfq6bmg1o